title: [The management of Helicobacter pylori infection in adults--statement of the Polish Working Group and the Maastricht Consensus 2-2000].
abstract: Current standards in the management of Helicobacter pylori infection according to the guidelines by European (Maastricht 2-2000 Consensus Report) and Polish Study Group (IX Congress of Polish Gastroenterology Association) were presented in this paper. The comparison analysis was performed as well as the diagnostic methods were described. The indications for Helicobacter pylori infection treatment especially in gastric and duodenal ulcer disease (also complicated by bleeding), gastric precancerous conditions, functional dyspepsia, gastroesophageal reflux disease, non-steroidal anti-inflammatory therapy were discussed. The acceptable schedules of the first and second-line therapy as well as the problem of drug resistance were presented. The special attention was drown to differences between the two sets of guidelines with respect to latest scientific reports.
authors.affiliation: Katedry Chorób Wewnetrznych i Gerontologii Collegium Medicum Uniwersytetu Jagiellońskiego. klwewiger@su.krakow.pl
authors.forename: Aleksander J
authors.initials: AJ
authors.lastname: Kwater
authors.forename: Stefan
authors.initials: S
authors.lastname: Bednarz
authors.forename: Tomasz K
authors.initials: TK
authors.lastname: Grodzicki
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D024881:Drug Resistance, Bacterial; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D016145:Endoscopy, Digestive System / Q000592:standards; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D011230:Precancerous Conditions / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D018570:Risk Assessment; D012698:Serologic Tests / Q000592:standards; D013276:Stomach Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents